Sagandipine

This classification denotes a calcium channel blocker with the molecular formula C27H31FN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 20O65J0B72, chemically known as methyl (5-piperidinomethyl)furfuryl 4-(o-fluorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate. but generally known as sagandipine, which bears US NIH Compound Identifier 3058740. European Medicines Agency schedules Sagandipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10414MIG. The term SAGANDIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). SAGANDIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sagandipine under HS 29349990 and SITC 51579. As of Q4 2014, SAGANDIPINE remains the US FDA Preferred Term for this commodity. Sagandipine bears US NLM identifiers UMLS ID C2348129 and NCI Concept Code C73028. SMILES: Fc1c(C2C(=C(NC(=C2C(=O)OC)C)C)C(=O)OCc2oc(CN3CCCCC3)cc2)cccc1.